Developer docs
API playgroundTry for free, no card

Search company profiles

The Sumaira Foundation

Full company profile

uuid003lorm

Namestring
The Sumaira Foundation
Legal namestring
The Sumaira Foundation, Inc.
Company typeenum
Private
Founded yearint
2014
Descriptiontext

The Sumaira Foundation (TSF) is a patient-led, science-driven 501(c)(3) nonprofit organization founded in 2014 by Sumaira Ahmed following her diagnosis of Neuromyelitis Optica Spectrum Disorder (NMOSD). Headquartered in Brookline, Massachusetts, the organization is dedicated to raising global awareness of rare neuroimmune conditions — primarily NMOSD, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD), and Myasthenia Gravis (MG) — and operates support, education, research, and advocacy programs serving patients, caregivers, and clinicians across multiple continents. Core offerings include patient education resources (brochures, diagnostic criteria documents, therapy charts, podcasts such as Demystifying NMO & MOG, and the "From the Experts" webinar series), community programs (the Human Collective Project support groups, Mental Health Mondays, caregiver support, Patient Days at institutions such as Mayo Clinic, Brigham and Women's, Massachusetts General, Oxford, and Charité Berlin), research funding (TSF-funded grants, fellowships, journal publications, and the Global Rare Trailblazer Award), advocacy tools (Brain Health Report, insurance navigation guides, shared decision-making guides), and financial assistance programs for affected patients and families.

TSF is not a technology product company and does not develop proprietary technology platforms. Its operational backbone is a global ambassador network, an international Medical Advisory Board, and multi-channel awareness infrastructure spanning seven social media platforms, podcasts, events, and earned media coverage in outlets such as CNBC, Neurology Live, Brain & Life Magazine, and Financial Times. Revenue is generated through a mix of tax-deductible individual donations, corporate sponsorships from rare neuroimmune pharma companies (Alexion/AstraZeneca Rare Disease, Amgen, argenx, Genentech, Roche, UCB, Johnson & Johnson, EUROIMMUN, Portal Instruments), merchandise sales via Bonfire and Square e-commerce storefronts, and the AmazonSmile affiliate program. The organization holds 501(c)(3) tax-exempt status (Charitable ID#: 47-2398246) and is governed by an independent Board of Directors.

TSF has scaled from a local Boston-based initiative to an international advocacy platform through a combination of organic program expansion and inorganic moves, including the August 2022 acquisition of the Connor B. Judge Foundation, the February 2023 launch of TSF France, and a June 2026 real-world data partnership with Citizen Health. It operates an international Medical Advisory Board including experts from Mayo Clinic and Korle-Bu Teaching Hospital in Ghana, and maintains global reach across North America, Europe, Asia, South America, and Africa.

Short descriptiontext

The Sumaira Foundation is a patient-led 501(c)(3) nonprofit founded in 2014 that raises global awareness of rare neuroimmune conditions including NMOSD, MOGAD, and Myasthenia Gravis, serving patients, caregivers, clinicians, and researchers across multiple continents through education, support, research funding, and advocacy programs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBrookline, United States
HQ citystring
Brookline
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rare disease advocacy, patient support services, neuroimmune disease awareness, medical research funding, patient education resources
Industry2 codes
PRIMARYBPAGACAM
Rare Disease & Special Needs Support Organizations
SECONDARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
NAICS code2 codes
  • Voluntary Health Organizations813212
  • Other Individual and Family Services624190
SIC code2 codes
  • Services-Misc Health & Allied Services, Nec8090
  • Services-Social Services8300
Product category
Patient Advocacy Services
Revenue model4 records
1Donations and Charitable Contributions
TypeGrants Donations
Description

Tax-deductible donations from individuals supporting rare neuroimmune disease awareness and research. The organization is a 501(c)(3) tax-exempt organization with Charitable ID#: 47-2398246.

sumairafoundation.org
2Corporate Sponsorships and Industry Partnerships
TypeOthers
Description

Funding and support from pharmaceutical companies including Alexion, Amgen, argenx, AstraZeneca, Genentech, Roche, UCB, and others who partner with the foundation for patient advocacy initiatives.

sumairafoundation.org
3Merchandise Sales
TypeOthers
Description

Sales of merchandise through Bonfire store and Square e-commerce site, including Unicorns products and branded items.

sumairafoundation.org
4AmazonSmile Program
TypeAffiliate Referral
Description

Amazon donates 0.5% of eligible purchases when customers select The Sumaira Foundation as their charitable organization.

sumairafoundation.org
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

The Sumaira Foundation is a 501(c)(3) nonprofit that delivers awareness, education, support, advocacy, and research funding programs for patients with rare neuroimmune conditions, specifically Neuromyelitis Optica Spectrum Disorder (NMOSD), Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD), and Myasthenia Gravis (MG). It operates support groups (Human Collective Project), caregiver programs, mental health resources, financial assistance, fellowships and funded research, global ambassador communities, and branded merchandise, alongside partnerships with pharmaceutical companies and academic medical centers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

The Sumaira Foundation (TSF) is a patient-led 501(c)(3) nonprofit organization dedicated to raising awareness of rare neuroimmune conditions, specifically NMOSD (Neuromyelitis Optica Spectrum Disorder), MOGAD (Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease), and Myasthenia Gravis. The foundation operates as a resource and support organization rather than a technology product company. Its offerings include patient education and support programs (Human Collective Project support groups, Mental Health Mondays, caregiver support), research funding and fellowships, global ambassador networks, financial assistance programs, advocacy resources, educational brochures, and community events. The organization connects patients with resources, funds research initiatives, and builds global communities through ambassador programs and awareness campaigns.

Product and service7 records
1Patient Education and Support Programs
CategoryPatient Support Programs
Description

Comprehensive support services including support groups (Human Collective Project), Mental Health Mondays, caregiver support groups, patient stories (Voices of TSF), and patient days for individuals with NMOSD, MOGAD, and MG.

2Research Funding and Fellowships
CategoryResearch Funding
Description

TSF-funded research grants, fellowships for researchers, journal publications, research summaries, and the Global Rare Trailblazer Award recognizing contributions to rare disease research.

3Financial Assistance Programs
CategoryPatient Financial Assistance
Description

Assistance programs providing financial support to patients and caregivers affected by rare neuroimmune diseases.

4Global Ambassador Program
CategoryCommunity Engagement Program
Description

Network of TSF ambassadors representing the foundation globally across multiple continents, languages, and communities to support patients and caregivers.

5Events and Community Gatherings
CategoryEvents and Community Engagement
Description

Calendar of events including patient days, support group meetings, fundraising events, educational webinars, and awareness campaigns across multiple countries.

6TSF Merchandise (Unicorns Shop)
CategoryBranded Merchandise
Description

Online merchandise store featuring unicorn-themed items representing the foundation's symbol, available through the Bonfire store and Square Unicorns shop.

7Educational Brochures and Infographics
CategoryPatient Education Materials
Description

Patient education brochures on understanding NMOSD and MOGAD, research infographics, and accessible informational materials available for ordering.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-01
Description

The Sumaira Foundation selected Citizen Health as its real-world data partner in June 2026. This partnership supports TSF's research initiatives by providing access to real-world patient data for rare neuroimmune disease research.

Strategic tierMajorTypeGTM or Marketing Partner
Description

Alexion, AstraZeneca Rare Disease, is an industry partner supporting TSF's awareness and advocacy initiatives for NMOSD and MOGAD patients. Alexion has been featured in TSF's media coverage and patient engagement activities.

Strategic tierMajorTypeGTM or Marketing Partner
Description

Amgen is an industry partner supporting rare neuroimmune disease awareness. Featured in TSF's storytelling and advocacy efforts, including coverage of founder Sumaira Ahmed's journey.

Strategic tierMajorTypeGTM or Marketing Partner
Description

argenx is an industry partner supporting TSF's mission for rare neuroimmune disease awareness and patient advocacy.

Strategic tierMajorTypeGTM or Marketing Partner
Description

AstraZeneca, through its Rare Disease division (Alexion), partners with TSF to support awareness, advocacy, and patient resources for NMOSD and related conditions.

Strategic tierMinorTypeGTM or Marketing Partner
Description

EUROIMMUN is an industry partner contributing to TSF's awareness initiatives, including educational content about MOGAD.

Strategic tierMajorTypeGTM or Marketing Partner
Description

Genentech is a long-standing industry partner that has featured TSF founder Sumaira Ahmed in patient advocacy content and supports community building initiatives.

Strategic tierMajorTypeGTM or Marketing Partner
Description

Johnson & Johnson is an industry partner supporting TSF's rare neuroimmune disease awareness and advocacy efforts.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Portal Instruments partnered with The Sumaira Foundation in March 2021 to support NMO patient communities.

Strategic tierMajorTypeGTM or Marketing Partner
Description

Roche is an industry partner supporting TSF's rare neuroimmune disease advocacy and awareness initiatives.

11UCB
Strategic tierMajorTypeGTM or Marketing Partner
Description

UCB is an industry partner supporting TSF's mission to raise awareness and provide support for rare neuroimmune conditions.

12Connor B. Judge Foundation
Strategic tierCoreTypeStrategic or Co-development Partner
Description

In August 2022, The Sumaira Foundation announced the acquisition of the Connor B. Judge Foundation, expanding its reach and resources for the rare neuroimmune disease community.

sumairafoundation.org
13The Transverse Myelitis Association
Strategic tierMajorTypeStrategic or Co-development Partner
Description

The Transverse Myelitis Association (TMA) announced its partnership with TSF in October 2018, combining resources and advocacy efforts for rare neuroimmune conditions.

sumairafoundation.org
14Guthy-Jackson Charitable Foundation
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Guthy-Jackson Charitable Foundation is acknowledged as a partner supporting New England NMO Patient Day events and collaboration with TSF.

sumairafoundation.org
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeOthers
Description

Major TSF industry partner and developer of Soliris/Ultomiris for NMOSD. Comparable patient community engagement programming and overlapping rare-neuroimmune therapeutic focus; partner-ecosystem comparable rather than direct competitor.

TypeBroad incumbent
Description

Umbrella advocacy organization for the broader rare disease community. Larger scale, broader portfolio of conditions; serves as a complement to TSF's narrow NMOSD/MOGAD/MG focus and competes for the same pharma partnership dollars.

3Guthy-Jackson Charitable Foundation
TypeDirect peer
Description

The most direct peer — a charitable foundation singularly focused on NMO/NMOSD, co-hosts New England NMO Patient Day with TSF. Comparable mission, patient population, and pharma sponsor mix.

TypeBroad incumbent
Description

Allied rare-disease advocacy and patient empowerment organization. Comparable awareness, education, and community-building mission but at a broader scale and with a wider disease portfolio.

TypeEmerging player
Description

Patient-led, science-driven advocacy organization with a comparable operating playbook (founder-led, research funding, awareness campaigns, global ambassador model), focused on a different but adjacent brain-injury patient population.

TypeDirect peer
Description

National voluntary health organization dedicated to Myasthenia Gravis — directly overlapping one of TSF's three disease pillars. Similar revenue model (donations, pharma sponsorships) and comparable research-funding and patient-support programs.

7Rare Diseases Clinical Research Network
TypeOthers
Description

NIH-funded consortium that conducts collaborative clinical research on rare diseases. Functions as a research infrastructure peer and potential research-funding collaborator for TSF's fellowship and grants programs.

8The Transverse Myelitis Association
TypeDirect peer
Description

Long-standing TSF partner (since 2018) and peer organization serving rare neuroimmune conditions including transverse myelitis and related disorders. Overlapping patient community and similar awareness/advocacy programming.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Sumaira Foundation

Patient Advocacy Servicessumairafoundation.org

The Sumaira Foundation is a patient-led 501(c)(3) nonprofit founded in 2014 that raises global awareness of rare neuroimmune conditions including NMOSD, MOGAD, and Myasthenia Gravis, serving patients, caregivers, clinicians, and researchers across multiple continents through education, support, research funding, and advocacy programs.

What The Sumaira Foundation does

The Sumaira Foundation (TSF) is a patient-led, science-driven 501(c)(3) nonprofit organization founded in 2014 by Sumaira Ahmed following her diagnosis of Neuromyelitis Optica Spectrum Disorder (NMOSD). Headquartered in Brookline, Massachusetts, the organization is dedicated to raising global awareness of rare neuroimmune conditions — primarily NMOSD, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD), and Myasthenia Gravis (MG) — and operates support, education, research, and advocacy programs serving patients, caregivers, and clinicians across multiple continents. Core offerings include patient education resources (brochures, diagnostic criteria documents, therapy charts, podcasts such as Demystifying NMO & MOG, and the "From the Experts" webinar series), community programs (the Human Collective Project support groups, Mental Health Mondays, caregiver support, Patient Days at institutions such as Mayo Clinic, Brigham and Women's, Massachusetts General, Oxford, and Charité Berlin), research funding (TSF-funded grants, fellowships, journal publications, and the Global Rare Trailblazer Award), advocacy tools (Brain Health Report, insurance navigation guides, shared decision-making guides), and financial assistance programs for affected patients and families.

TSF is not a technology product company and does not develop proprietary technology platforms. Its operational backbone is a global ambassador network, an international Medical Advisory Board, and multi-channel awareness infrastructure spanning seven social media platforms, podcasts, events, and earned media coverage in outlets such as CNBC, Neurology Live, Brain & Life Magazine, and Financial Times. Revenue is generated through a mix of tax-deductible individual donations, corporate sponsorships from rare neuroimmune pharma companies (Alexion/AstraZeneca Rare Disease, Amgen, argenx, Genentech, Roche, UCB, Johnson & Johnson, EUROIMMUN, Portal Instruments), merchandise sales via Bonfire and Square e-commerce storefronts, and the AmazonSmile affiliate program. The organization holds 501(c)(3) tax-exempt status (Charitable ID#: 47-2398246) and is governed by an independent Board of Directors.

TSF has scaled from a local Boston-based initiative to an international advocacy platform through a combination of organic program expansion and inorganic moves, including the August 2022 acquisition of the Connor B. Judge Foundation, the February 2023 launch of TSF France, and a June 2026 real-world data partnership with Citizen Health. It operates an international Medical Advisory Board including experts from Mayo Clinic and Korle-Bu Teaching Hospital in Ghana, and maintains global reach across North America, Europe, Asia, South America, and Africa.

The Sumaira Foundation firmographics

Firmographics
Name
The Sumaira Foundation
Legal name
The Sumaira Foundation, Inc.
Website
https://sumairafoundation.org
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
The Sumaira Foundation is a patient-led 501(c)(3) nonprofit founded in 2014 that raises global awareness of rare neuroimmune conditions including NMOSD, MOGAD, and Myasthenia Gravis, serving patients, caregivers, clinicians, and researchers across multiple continents through education, support, research funding, and advocacy programs.
Ownership category
akta.pro rank

The Sumaira Foundation industry classification

Industry
Product category
Patient Advocacy Services
NAICS
Voluntary Health Organizations (813212), Other Individual and Family Services (624190)
SIC
Services-Misc Health & Allied Services, Nec (8090), Services-Social Services (8300)
akta.pro industry
PRIMARYBPAGACAM
Rare Disease & Special Needs Support Organizations
SECONDARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking

Keywords

  • Rare disease advocacy
  • Patient support services
  • Neuroimmune disease awareness
  • Medical research funding
  • Patient education resources

Where The Sumaira Foundation is headquartered

Location

Headquarters

HQ city
Brookline
HQ country
United States
HQ region
North America

Offices1 record

Markets served

The Sumaira Foundation business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Donations and Charitable Contributions: Tax-deductible donations from individuals supporting rare neuroimmune disease awareness and research. The organization is a 501(c)(3) tax-exempt organization with Charitable ID#: 47-2398246.
  2. Corporate Sponsorships and Industry Partnerships: Funding and support from pharmaceutical companies including Alexion, Amgen, argenx, AstraZeneca, Genentech, Roche, UCB, and others who partner with the foundation for patient advocacy initiatives.
  3. Merchandise Sales: Sales of merchandise through Bonfire store and Square e-commerce site, including Unicorns products and branded items.
  4. AmazonSmile Program: Amazon donates 0.5% of eligible purchases when customers select The Sumaira Foundation as their charitable organization.

Distribution channels4 records

Marketing channels8 records

The Sumaira Foundation product offering

Product offering

Core offering

The Sumaira Foundation is a 501(c)(3) nonprofit that delivers awareness, education, support, advocacy, and research funding programs for patients with rare neuroimmune conditions, specifically Neuromyelitis Optica Spectrum Disorder (NMOSD), Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD), and Myasthenia Gravis (MG). It operates support groups (Human Collective Project), caregiver programs, mental health resources, financial assistance, fellowships and funded research, global ambassador communities, and branded merchandise, alongside partnerships with pharmaceutical companies and academic medical centers.

Product overview

The Sumaira Foundation (TSF) is a patient-led 501(c)(3) nonprofit organization dedicated to raising awareness of rare neuroimmune conditions, specifically NMOSD (Neuromyelitis Optica Spectrum Disorder), MOGAD (Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease), and Myasthenia Gravis. The foundation operates as a resource and support organization rather than a technology product company. Its offerings include patient education and support programs (Human Collective Project support groups, Mental Health Mondays, caregiver support), research funding and fellowships, global ambassador networks, financial assistance programs, advocacy resources, educational brochures, and community events. The organization connects patients with resources, funds research initiatives, and builds global communities through ambassador programs and awareness campaigns.

Differentiator

Problem solved

Functional benefit

Products and services

  • Patient Education and Support Programs Comprehensive support services including support groups (Human Collective Project), Mental Health Mondays, caregiver support groups, patient stories (Voices of TSF), and patient days for individuals with NMOSD, MOGAD, and MG.
  • Research Funding and Fellowships TSF-funded research grants, fellowships for researchers, journal publications, research summaries, and the Global Rare Trailblazer Award recognizing contributions to rare disease research.
  • Financial Assistance Programs Assistance programs providing financial support to patients and caregivers affected by rare neuroimmune diseases.
  • Global Ambassador Program Network of TSF ambassadors representing the foundation globally across multiple continents, languages, and communities to support patients and caregivers.
  • Events and Community Gatherings Calendar of events including patient days, support group meetings, fundraising events, educational webinars, and awareness campaigns across multiple countries.
  • TSF Merchandise (Unicorns Shop) Online merchandise store featuring unicorn-themed items representing the foundation's symbol, available through the Bonfire store and Square Unicorns shop.
  • Educational Brochures and Infographics Patient education brochures on understanding NMOSD and MOGAD, research infographics, and accessible informational materials available for ordering.

Companies that use The Sumaira Foundation

Customer profile

Segments4 records

Ideal customer profiles3 records

The Sumaira Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

The Sumaira Foundation partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core, major and minor.

  • Citizen HealthcoreStrategic or Co-development Partner · 1 June 2026The Sumaira Foundation selected Citizen Health as its real-world data partner in June 2026. This partnership supports TSF's research initiatives by providing access to real-world patient data for rare neuroimmune disease research.
  • AlexionmajorGTM or Marketing PartnerAlexion, AstraZeneca Rare Disease, is an industry partner supporting TSF's awareness and advocacy initiatives for NMOSD and MOGAD patients. Alexion has been featured in TSF's media coverage and patient engagement activities.
  • AmgenmajorGTM or Marketing PartnerAmgen is an industry partner supporting rare neuroimmune disease awareness. Featured in TSF's storytelling and advocacy efforts, including coverage of founder Sumaira Ahmed's journey.
  • argenxmajorGTM or Marketing Partnerargenx is an industry partner supporting TSF's mission for rare neuroimmune disease awareness and patient advocacy.
  • AstraZenecamajorGTM or Marketing PartnerAstraZeneca, through its Rare Disease division (Alexion), partners with TSF to support awareness, advocacy, and patient resources for NMOSD and related conditions.
  • EUROIMMUNminorGTM or Marketing PartnerEUROIMMUN is an industry partner contributing to TSF's awareness initiatives, including educational content about MOGAD.
  • GenentechmajorGTM or Marketing PartnerGenentech is a long-standing industry partner that has featured TSF founder Sumaira Ahmed in patient advocacy content and supports community building initiatives.
  • Johnson & JohnsonmajorGTM or Marketing PartnerJohnson & Johnson is an industry partner supporting TSF's rare neuroimmune disease awareness and advocacy efforts.
  • Portal InstrumentsminorGTM or Marketing PartnerPortal Instruments partnered with The Sumaira Foundation in March 2021 to support NMO patient communities.
  • RochemajorGTM or Marketing PartnerRoche is an industry partner supporting TSF's rare neuroimmune disease advocacy and awareness initiatives.
  • UCBmajorGTM or Marketing PartnerUCB is an industry partner supporting TSF's mission to raise awareness and provide support for rare neuroimmune conditions.
  • Connor B. Judge FoundationcoreStrategic or Co-development PartnerIn August 2022, The Sumaira Foundation announced the acquisition of the Connor B. Judge Foundation, expanding its reach and resources for the rare neuroimmune disease community.
  • The Transverse Myelitis AssociationmajorStrategic or Co-development PartnerThe Transverse Myelitis Association (TMA) announced its partnership with TSF in October 2018, combining resources and advocacy efforts for rare neuroimmune conditions.
  • Guthy-Jackson Charitable FoundationmajorStrategic or Co-development PartnerGuthy-Jackson Charitable Foundation is acknowledged as a partner supporting New England NMO Patient Day events and collaboration with TSF.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

The Sumaira Foundation competitors and assessment

Company assessment

Others

  • Alexion / AstraZeneca Rare Disease: Major TSF industry partner and developer of Soliris/Ultomiris for NMOSD. Comparable patient community engagement programming and overlapping rare-neuroimmune therapeutic focus; partner-ecosystem comparable rather than direct competitor.
  • Rare Diseases Clinical Research Network: NIH-funded consortium that conducts collaborative clinical research on rare diseases. Functions as a research infrastructure peer and potential research-funding collaborator for TSF's fellowship and grants programs.

Broad incumbents

  • National Organization for Rare Disorders (NORD): Umbrella advocacy organization for the broader rare disease community. Larger scale, broader portfolio of conditions; serves as a complement to TSF's narrow NMOSD/MOGAD/MG focus and competes for the same pharma partnership dollars.
  • Global Genes: Allied rare-disease advocacy and patient empowerment organization. Comparable awareness, education, and community-building mission but at a broader scale and with a wider disease portfolio.

Direct peers

  • Guthy-Jackson Charitable Foundation: The most direct peer — a charitable foundation singularly focused on NMO/NMOSD, co-hosts New England NMO Patient Day with TSF. Comparable mission, patient population, and pharma sponsor mix.
  • Myasthenia Gravis Foundation of America: National voluntary health organization dedicated to Myasthenia Gravis — directly overlapping one of TSF's three disease pillars. Similar revenue model (donations, pharma sponsorships) and comparable research-funding and patient-support programs.
  • The Transverse Myelitis Association: Long-standing TSF partner (since 2018) and peer organization serving rare neuroimmune conditions including transverse myelitis and related disorders. Overlapping patient community and similar awareness/advocacy programming.

Emerging players

  • Concussion Legacy Foundation: Patient-led, science-driven advocacy organization with a comparable operating playbook (founder-led, research funding, awareness campaigns, global ambassador model), focused on a different but adjacent brain-injury patient population.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

The Sumaira Foundation social profiles

Digital presence

The Sumaira Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Sumaira Foundation leadership team

Management profile

Number of profiles

Profiles11 records

The Sumaira Foundation subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

The Sumaira Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Sumaira Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Sumaira Foundation

What does The Sumaira Foundation do?

The Sumaira Foundation is a 501(c)(3) nonprofit that delivers awareness, education, support, advocacy, and research funding programs for patients with rare neuroimmune conditions, specifically Neuromyelitis Optica Spectrum Disorder (NMOSD), Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD), and Myasthenia Gravis (MG). It operates support groups (Human Collective Project), caregiver programs, mental health resources, financial assistance, fellowships and funded research, global ambassador communities, and branded merchandise, alongside partnerships with pharmaceutical companies and academic medical centers.

Is The Sumaira Foundation a public or private company?

The Sumaira Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was The Sumaira Foundation founded?

The Sumaira Foundation was founded in 2014. It employs 11 to 50 people.

Where is The Sumaira Foundation based?

The Sumaira Foundation is headquartered in Brookline, United States, in the North America region.

How does The Sumaira Foundation make money?

Four revenue lines are on record. Donations and Charitable Contributions are the primary driver. The others are corporate Sponsorships and Industry Partnerships, merchandise Sales and amazonSmile Program.

Who are The Sumaira Foundation's main competitors?

Others on record are Alexion / AstraZeneca Rare Disease and Rare Diseases Clinical Research Network. Broad incumbents are National Organization for Rare Disorders (NORD) and Global Genes. Direct peers are Guthy-Jackson Charitable Foundation, Myasthenia Gravis Foundation of America and The Transverse Myelitis Association. Concussion Legacy Foundation is listed as an emerging player.

Does The Sumaira Foundation have an API?

No public API is recorded for The Sumaira Foundation.

What industry is The Sumaira Foundation in?

The Sumaira Foundation's product category is Patient Advocacy Services. Its primary akta.pro industry code is BPAGACAM, Rare Disease & Special Needs Support Organizations, with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 813212 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales